- Home
- EZGO vs PPBT Comparison
EZGO vs PPBT Comparison
Compare EZGO & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZGO
- PPBT
- Stock Information
- Founded
- EZGO 2014
- PPBT 2010
- Country
- EZGO China
- PPBT Israel
- Employees
- EZGO N/A
- PPBT N/A
- Industry
- EZGO Motor Vehicles
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- EZGO Consumer Discretionary
- PPBT Health Care
- Exchange
- EZGO Nasdaq
- PPBT Nasdaq
- Market Cap
- EZGO 1.8M
- PPBT 2.1M
- IPO Year
- EZGO 2021
- PPBT N/A
- Fundamental
- Price
- EZGO $0.13
- PPBT $0.57
- Analyst Decision
- EZGO
- PPBT Strong Buy
- Analyst Count
- EZGO 0
- PPBT 1
- Target Price
- EZGO N/A
- PPBT $33.00
- AVG Volume (30 Days)
- EZGO 7.2M
- PPBT 2.8M
- Earning Date
- EZGO 07-01-2025
- PPBT 08-06-2025
- Dividend Yield
- EZGO N/A
- PPBT N/A
- EPS Growth
- EZGO N/A
- PPBT N/A
- EPS
- EZGO N/A
- PPBT N/A
- Revenue
- EZGO $20,895,830.00
- PPBT N/A
- Revenue This Year
- EZGO N/A
- PPBT N/A
- Revenue Next Year
- EZGO N/A
- PPBT N/A
- P/E Ratio
- EZGO N/A
- PPBT N/A
- Revenue Growth
- EZGO 18.98
- PPBT N/A
- 52 Week Low
- EZGO $0.11
- PPBT $0.53
- 52 Week High
- EZGO $1.47
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- EZGO 24.64
- PPBT 11.95
- Support Level
- EZGO $0.11
- PPBT $0.53
- Resistance Level
- EZGO $0.13
- PPBT $2.36
- Average True Range (ATR)
- EZGO 0.02
- PPBT 0.16
- MACD
- EZGO -0.01
- PPBT -0.13
- Stochastic Oscillator
- EZGO 5.58
- PPBT 2.05
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.